ALT 0 3 0 3 B-clinical_variable
and 4 7 4 7 I-clinical_variable
AST 8 11 8 11 I-clinical_variable
≤ 12 13 12 13 O
3.0 14 17 14 17 B-upper_bound
x 18 19 18 19 I-upper_bound
upper 20 25 20 25 I-upper_bound
limits 26 32 26 32 I-upper_bound
of 33 35 33 35 I-upper_bound
normal 36 42 36 42 I-upper_bound
( 43 44 43 44 I-upper_bound
ULN 44 47 44 47 I-upper_bound
) 47 48 47 48 I-upper_bound
For 49 52 49 52 O
patients 53 61 53 61 O
with 62 66 62 66 O
liver 67 72 67 72 B-cancer
metastasis 73 83 73 83 I-cancer
: 83 84 83 84 O
< 85 86 85 86 O
5 87 88 87 88 B-upper_bound
x 89 90 89 90 I-upper_bound
upper 91 96 91 96 I-upper_bound
limits 97 103 97 103 I-upper_bound
of 104 106 104 106 I-upper_bound
normal 107 113 107 113 I-upper_bound
( 114 115 114 115 I-upper_bound
ULN 115 118 115 118 I-upper_bound
) 118 119 118 119 I-upper_bound

An 0 2 120 122 O
elevated 3 11 123 131 O
serum 12 17 132 137 B-clinical_variable
gonadotropin 18 30 138 150 I-clinical_variable
level 31 36 151 156 I-clinical_variable
and 37 40 157 160 O
estradiol 41 50 161 170 B-clinical_variable
level 51 56 171 176 I-clinical_variable
in 57 59 177 179 O
the 60 63 180 183 O
postmenopausal 64 78 184 198 O
range 79 84 199 204 O
( 85 86 205 206 O
as 86 88 206 208 O
locally 89 96 209 216 O
defined 97 104 217 224 O
) 104 105 224 225 O
can 106 109 226 229 O
be 110 112 230 232 O
used 113 117 233 237 O
to 118 120 238 240 O
confirm 121 128 241 248 O
menopausal 129 139 249 259 O
status 140 146 260 266 O
in 147 149 267 269 O
a 150 151 270 271 O
subject 152 159 272 279 O
with 160 164 280 284 O
< 165 166 285 286 O
1 166 167 286 287 B-upper_bound
year 168 172 288 292 I-upper_bound
of 173 175 293 295 O
amenorrhea 176 186 296 306 B-chronic_disease

Anti 0 4 307 311 B-treatment
- 4 5 311 312 I-treatment
resorptive 5 15 312 322 I-treatment
bone 16 20 323 327 I-treatment
therapies 21 30 328 337 I-treatment
( 31 32 338 339 O
e.g. 32 36 339 343 O
, 36 37 343 344 O
bisphosphonates 38 53 345 360 B-treatment
, 53 54 360 361 O
denosumab 55 64 362 371 B-treatment
) 64 65 371 372 O
are 66 69 373 376 O
permitted 70 79 377 386 O

Any 0 3 387 390 O
investigational 4 19 391 406 B-treatment
cancer 20 26 407 413 I-treatment
therapy 27 34 414 421 I-treatment
in 35 37 422 424 O
the 38 41 425 428 O
last 42 46 429 433 B-upper_bound
28 47 49 434 436 I-upper_bound
days 50 54 437 441 I-upper_bound

Any 0 3 442 445 O
number 4 10 446 452 O
of 11 13 453 455 O
prior 14 19 456 461 O
lines 20 25 462 467 O
of 26 28 468 470 O
anti 29 33 471 475 B-treatment
- 33 34 475 476 I-treatment
estrogen 34 42 476 484 I-treatment
( 43 44 485 486 O
i.e. 44 48 486 490 O
, 48 49 490 491 O
hormonal 50 58 492 500 O
) 58 59 500 501 O
therapy 60 67 502 509 B-treatment
is 68 70 510 512 O
permissible 71 82 513 524 O

Any 0 3 525 528 O
other 4 9 529 534 O
concurrent 10 20 535 545 O
systemic 21 29 546 554 B-treatment
anti 30 34 555 559 I-treatment
- 34 35 559 560 I-treatment
cancer 35 41 560 566 I-treatment
treatments 42 52 567 577 I-treatment
, 52 53 577 578 O
including 54 63 579 588 O
conventional 64 76 589 601 B-treatment
chemotherapeutic 77 93 602 618 I-treatment
agents 94 100 619 625 I-treatment
and 101 104 626 629 O
biological 105 115 630 640 B-treatment
agents 116 122 641 647 I-treatment
, 122 123 647 648 O
during 124 130 649 655 O
the 131 134 656 659 O
study 135 140 660 665 O
period 141 147 666 672 O

Archived 0 8 673 681 O
tumor 9 14 682 687 B-cancer
specimens 15 24 688 697 O
: 24 25 697 698 O
Excess 26 32 699 705 O
tumor 33 38 706 711 O
tissue 39 45 712 718 O
must 46 50 719 723 O
be 51 53 724 726 O
available 54 63 727 736 O
for 64 67 737 740 O
research 68 76 741 749 O
purposes 77 85 750 758 O

Baseline 0 8 759 767 O
radiographic 9 21 768 780 O
staging 22 29 781 788 O
, 29 30 788 789 O
including 31 40 790 799 O
specifically 41 53 800 812 O
either 54 60 813 819 O
PET 61 64 820 823 B-treatment
/ 64 65 823 824 I-treatment
CT 65 67 824 826 I-treatment
, 67 68 826 827 O
or 69 71 828 830 O
CT 72 74 831 833 B-treatment
( 75 76 834 835 I-treatment
CAP 76 79 835 838 I-treatment
) 79 80 838 839 I-treatment
and 81 84 840 843 O
bone 85 89 844 848 B-treatment
scan 90 94 849 853 I-treatment

Combination 0 11 854 865 O
regimens 12 20 866 874 O
that 21 25 875 879 O
include 26 33 880 887 O
an 34 36 888 890 O
anti 37 41 891 895 B-treatment
- 41 42 895 896 I-treatment
estrogen 42 50 896 904 I-treatment
and 51 54 905 908 O
any 55 58 909 912 O
biologic 59 67 913 921 B-treatment
, 67 68 921 922 O
or 69 71 923 925 O
targeted 72 80 926 934 B-treatment
therapy 81 88 935 942 I-treatment
, 88 89 942 943 O
are 90 93 944 947 O
permitted 94 103 948 957 O
( 104 105 958 959 O
e.g. 105 109 959 963 O
, 109 110 963 964 O
any 111 114 965 968 O
CDK 115 118 969 972 B-treatment
inhibitor 119 128 973 982 I-treatment
, 128 129 982 983 O
everolimus 130 140 984 994 B-treatment
, 140 141 994 995 O
or 142 144 996 998 O
any 145 148 999 1002 O
other 149 154 1003 1008 O
novel 155 160 1009 1014 B-treatment
biologics 161 170 1015 1024 I-treatment
) 170 171 1024 1025 O
, 171 172 1025 1026 O
and 173 176 1027 1030 O
are 177 180 1031 1034 O
considered 181 191 1035 1045 O
to 192 194 1046 1048 O
be 195 197 1049 1051 O
a 198 199 1052 1053 O
single 200 206 1054 1060 O
hormonal 207 215 1061 1069 B-treatment
therapy 216 223 1070 1077 I-treatment
based 224 229 1078 1083 O
regimen 230 237 1084 1091 O

ER 0 2 1092 1094 O
strongly+ 3 12 1095 1104 O
status 13 19 1105 1111 O
defined 20 27 1112 1119 O
as 28 30 1120 1122 O
ER 31 33 1123 1125 B-treatment
staining 34 42 1126 1134 I-treatment
by 43 45 1135 1137 I-treatment
immunohistochemistry 46 66 1138 1158 I-treatment
in 67 69 1159 1161 O
≥50 70 73 1162 1165 O
% 73 74 1165 1166 I-lower_bound
of 75 77 1167 1169 O
malignant 78 87 1170 1179 B-clinical_variable
cell 88 92 1180 1184 I-clinical_variable
nuclei 93 99 1185 1191 I-clinical_variable
with 100 104 1192 1196 O
an 105 107 1197 1199 O
intensity 108 117 1200 1209 B-clinical_variable
≥2 118 120 1210 1212 O
+ 120 121 1212 1213 I-lower_bound
on 122 124 1214 1216 O
a 125 126 1217 1218 O
scale 127 132 1219 1224 O
of 133 135 1225 1227 O
0 136 137 1228 1229 O
- 137 138 1229 1230 O
3 138 139 1230 1231 B-upper_bound
+ 139 140 1231 1232 I-upper_bound

Freshly 0 7 1233 1240 O
acquired 8 16 1241 1249 O
tumor 17 22 1250 1255 B-cancer
specimens 23 32 1256 1265 O
: 32 33 1265 1266 O
As 34 36 1267 1269 O
part 37 41 1270 1274 O
of 42 44 1275 1277 O
a 45 46 1278 1279 O
clinically 47 57 1280 1290 O
indicated 58 67 1291 1300 O
biopsy 68 74 1301 1307 B-treatment
procedure 75 84 1308 1317 O
, 84 85 1317 1318 O
an 86 88 1319 1321 O
additional 89 99 1322 1332 O
1 100 101 1333 1334 B-lower_bound
- 101 102 1334 1335 O
3 102 103 1335 1336 B-upper_bound
cores 104 109 1337 1342 O
or 110 112 1343 1345 O
tissue 113 119 1346 1352 O
fragments 120 129 1353 1362 O
will 130 134 1363 1367 O
be 135 137 1368 1370 O
obtained 138 146 1371 1379 O
by 147 149 1380 1382 O
core 150 154 1383 1387 B-treatment
needle 155 161 1388 1394 I-treatment
or 162 164 1395 1397 O
surgical 165 173 1398 1406 B-treatment
biopsy 174 180 1407 1413 I-treatment
for 181 184 1414 1417 O
research 185 193 1418 1426 O
purposes 194 202 1427 1435 O
and 203 206 1436 1439 O
FFPE 207 211 1440 1444 B-treatment

HER2 0 4 1445 1449 B-clinical_variable
- 4 5 1449 1450 O
negative 5 13 1450 1458 O
status 14 20 1459 1465 O
is 21 23 1466 1468 O
defined 24 31 1469 1476 O
as 32 34 1477 1479 O
immunohistochemistry 35 55 1480 1500 B-clinical_variable
score 56 61 1501 1506 I-clinical_variable
of 62 64 1507 1509 O
0 65 66 1510 1511 B-lower_bound
- 66 67 1511 1512 O
1 67 68 1512 1513 B-upper_bound
+ 68 69 1513 1514 I-upper_bound
, 69 70 1514 1515 O
or 71 73 1516 1518 O
with 74 78 1519 1523 O
a 79 80 1524 1525 O
FISH 81 85 1526 1530 B-clinical_variable
ratio 86 91 1531 1536 I-clinical_variable
of 92 94 1537 1539 O
< 95 96 1540 1541 O
2 96 97 1541 1542 O
if 98 100 1543 1545 O
IHC 101 104 1546 1549 B-treatment
is 105 107 1550 1552 O
2 108 109 1553 1554 O
+ 109 110 1554 1555 O
or 111 113 1556 1558 O
if 114 116 1559 1561 O
IHC 117 120 1562 1565 O
has 121 124 1566 1569 O
not 125 128 1570 1573 O
been 129 133 1574 1578 O
done 134 138 1579 1583 O
( 139 140 1584 1585 O
as 140 142 1585 1587 O
per 143 146 1588 1591 O
ASCO 147 151 1592 1596 O
/ 151 152 1596 1597 O
CAP 152 155 1597 1600 O
definitions 156 167 1601 1612 O
) 167 168 1612 1613 O

Histologic 0 10 1614 1624 O
documentation 11 24 1625 1638 O
of 25 27 1639 1641 O
ER 28 30 1642 1644 O
strongly+/HER2- 31 46 1645 1660 O
breast 47 53 1661 1667 B-cancer
cancer 54 60 1668 1674 I-cancer
by 61 63 1675 1677 O
core 64 68 1678 1682 B-treatment
needle 69 75 1683 1689 I-treatment
biopsy 76 82 1690 1696 I-treatment
, 82 83 1696 1697 O
fine 84 88 1698 1702 B-treatment
needle 89 95 1703 1709 I-treatment
aspiration 96 106 1710 1720 I-treatment
, 106 107 1720 1721 O
incisional 108 118 1722 1732 B-treatment
biopsy 119 125 1733 1739 I-treatment

In 0 2 1740 1742 O
cases 3 8 1743 1748 O
of 9 11 1749 1751 O
borderline 12 22 1752 1762 O
or 23 25 1763 1765 O
equivocal 26 35 1766 1775 O
HER2 36 40 1776 1780 B-clinical_variable
status 41 47 1781 1787 O
, 47 48 1787 1788 O
eligibility 49 60 1789 1800 O
will 61 65 1801 1805 O
be 66 68 1806 1808 O
determined 69 79 1809 1819 O
by 80 82 1820 1822 O
the 83 86 1823 1826 O
PI 87 89 1827 1829 O

Known 0 5 1830 1835 O
CNS 6 9 1836 1839 B-chronic_disease
disease 10 17 1840 1847 I-chronic_disease
, 17 18 1847 1848 O
unless 19 25 1849 1855 O
clinically 26 36 1856 1866 O
stable 37 43 1867 1873 O
for 44 47 1874 1877 O
≥ 48 49 1878 1879 O
3 50 51 1880 1881 B-lower_bound
months 52 58 1882 1888 I-lower_bound

One 0 3 1889 1892 O
line 4 8 1893 1897 O
of 9 11 1898 1900 O
prior 12 17 1901 1906 B-treatment
chemotherapy 18 30 1907 1919 I-treatment
for 31 34 1920 1923 O
advanced 35 43 1924 1932 B-cancer
/ 43 44 1932 1933 O
metastatic 44 54 1933 1943 B-cancer
disease 55 62 1944 1951 I-cancer
is 63 65 1952 1954 O
permissible 66 77 1955 1966 O

Patient 0 7 1967 1974 O
must 8 12 1975 1979 O
be 13 15 1980 1982 O
a 16 17 1983 1984 O
candidate 18 27 1985 1994 O
for 28 31 1995 1998 O
treatment 32 41 1999 2008 B-treatment
with 42 46 2009 2013 I-treatment
17B 47 50 2014 2017 I-treatment
- 50 51 2017 2018 I-treatment
estradiol 51 60 2018 2027 I-treatment
and 61 64 2028 2031 O
an 65 67 2032 2034 O
aromatase 68 77 2035 2044 B-treatment
inhibitor 78 87 2045 2054 I-treatment

Patient 0 7 2055 2062 O
must 8 12 2063 2067 O
be 13 15 2068 2070 O
post 16 20 2071 2075 O
- 20 21 2075 2076 O
menopausal 21 31 2076 2086 O
based 32 37 2087 2092 O
on 38 40 2093 2095 O
either 41 47 2096 2102 O
a 48 49 2103 2104 O
history 50 57 2105 2112 O
of 58 60 2113 2115 O
an 61 63 2116 2118 O
oophorectomy 64 76 2119 2131 B-treatment
, 76 77 2131 2132 O
or 78 80 2133 2135 O
≥1 81 83 2136 2138 O
year 84 88 2139 2143 I-lower_bound
of 89 91 2144 2146 O
amenorrhea 92 102 2147 2157 O

Patient 0 7 2158 2165 O
must 8 12 2166 2170 O
have 13 17 2171 2175 O
been 18 22 2176 2180 O
treated 23 30 2181 2188 O
with 31 35 2189 2193 O
an 36 38 2194 2196 O
anti 39 43 2197 2201 B-treatment
- 43 44 2201 2202 I-treatment
estrogen 44 52 2202 2210 I-treatment
at 53 55 2211 2213 O
any 56 59 2214 2217 O
time 60 64 2218 2222 O
in 65 67 2223 2225 O
their 68 73 2226 2231 O
disease 74 81 2232 2239 O
history 82 89 2240 2247 O

Patients 0 8 2248 2256 O
with 9 13 2257 2261 O
bone 14 18 2262 2266 B-cancer
- 18 19 2266 2267 I-cancer
only 19 23 2267 2271 I-cancer
metastatic 24 34 2272 2282 I-cancer
disease 35 42 2283 2290 I-cancer
with 43 47 2291 2295 O
a 48 49 2296 2297 O
history 50 57 2298 2305 O
of 58 60 2306 2308 O
ER+/HER2- 61 70 2309 2318 B-clinical_variable
breast 71 77 2319 2325 B-cancer
cancer 78 84 2326 2332 I-cancer
are 85 88 2333 2336 O
eligible 89 97 2337 2345 O
, 97 98 2345 2346 O
and 99 102 2347 2350 O
bone 103 107 2351 2355 B-treatment
biopsy 108 114 2356 2362 I-treatment
is 115 117 2363 2365 O
not 118 121 2366 2369 O
required 122 130 2370 2378 O
, 130 131 2378 2379 O
providing 132 141 2380 2389 O
their 142 147 2390 2395 O
primary 148 155 2396 2403 O
cancer 156 162 2404 2410 O
is 163 165 2411 2413 O
consistent 166 176 2414 2424 O
with 177 181 2425 2429 O
the 182 185 2430 2433 O
above 186 191 2434 2439 O
- 191 192 2439 2440 O
described 192 201 2440 2449 O
ER 202 204 2450 2452 O
and 205 208 2453 2456 O
HER2 209 213 2457 2461 O
criteria 214 222 2462 2470 O

Patients 0 8 2471 2479 O
with 9 13 2480 2484 O
non 14 17 2485 2488 O
- 17 18 2488 2489 O
bone 18 22 2489 2493 O
metastatic 23 33 2494 2504 B-cancer
disease 34 41 2505 2512 I-cancer
in 42 44 2513 2515 O
whom 45 49 2516 2520 O
a 50 51 2521 2522 O
safe 52 56 2523 2527 O
and 57 60 2528 2531 O
accurate 61 69 2532 2540 O
biopsy 70 76 2541 2547 B-treatment
of 77 79 2548 2550 O
recurrent 80 89 2551 2560 O
/ 89 90 2560 2561 O
metastatic 90 100 2561 2571 O
disease 101 108 2572 2579 O
can 109 112 2580 2583 O
not 112 115 2583 2586 O
be 116 118 2587 2589 O
readily 119 126 2590 2597 O
obtained 127 135 2598 2606 O
are 136 139 2607 2610 O
also 140 144 2611 2615 O
eligible 145 153 2616 2624 O
, 153 154 2624 2625 O
providing 155 164 2626 2635 O
their 165 170 2636 2641 O
primary 171 178 2642 2649 B-cancer
cancer 179 185 2650 2656 I-cancer
is 186 188 2657 2659 O
consistent 189 199 2660 2670 O
with 200 204 2671 2675 O
the 205 208 2676 2679 O
above 209 214 2680 2685 O
- 214 215 2685 2686 O
described 215 224 2686 2695 O
ER 225 227 2696 2698 O
and 228 231 2699 2702 O
HER2 232 236 2703 2707 O
criteria 237 245 2708 2716 O

The 0 3 2717 2720 O
following 4 13 2721 2730 O
laboratory 14 24 2731 2741 O
values 25 31 2742 2748 O
must 32 36 2749 2753 O
be 37 39 2754 2756 O
confirmed 40 49 2757 2766 O
for 50 53 2767 2770 O
eligibility 54 65 2771 2782 O
within 66 72 2783 2789 O
28 73 75 2790 2792 B-upper_bound
days 76 80 2793 2797 I-upper_bound
prior 81 86 2798 2803 I-upper_bound
to 87 89 2804 2806 O
initiation 90 100 2807 2817 O
of 101 103 2818 2820 O
study 104 109 2821 2826 O
therapy 110 117 2827 2834 B-treatment

This 0 4 2835 2839 O
will 5 9 2840 2844 O
include 10 17 2845 2852 O
tumor 18 23 2853 2858 B-cancer
tissue 24 30 2859 2865 O
sufficient 31 41 2866 2876 O
to 42 44 2877 2879 O
make 45 49 2880 2884 O
≥10 50 53 2885 2888 O
five 54 58 2889 2893 I-lower_bound
- 58 59 2893 2894 I-lower_bound
micron 59 65 2894 2900 I-lower_bound
sections 66 74 2901 2909 I-lower_bound
; 74 75 2909 2910 O
more 76 80 2911 2915 O
tumor 81 86 2916 2921 O
tissue 87 93 2922 2928 O
is 94 96 2929 2931 O
preferred 97 106 2932 2941 O

Treatment 0 9 2942 2951 B-treatment
with 10 14 2952 2956 O
fulvestrant 15 26 2957 2968 B-treatment
within 27 33 2969 2975 O
4 34 35 2976 2977 B-upper_bound
months 36 42 2978 2984 I-upper_bound
prior 43 48 2985 2990 I-upper_bound
to 49 51 2991 2993 O
study 52 57 2994 2999 O
enrollment 58 68 3000 3010 O

Women 0 5 3011 3016 B-gender
≥18 6 9 3017 3020 O
years 10 15 3021 3026 I-lower_bound
of 16 18 3027 3029 O
age 19 22 3030 3033 B-age
with 23 27 3034 3038 O
clinical 28 36 3039 3047 O
stage 37 42 3048 3053 O
IV 43 45 3054 3056 O
ER+/HER2- 46 55 3057 3066 B-clinical_variable
breast 56 62 3067 3073 B-cancer
cancer 63 69 3074 3080 I-cancer
, 69 70 3080 3081 O
or 71 73 3082 3084 O
with 74 78 3085 3089 O
locally 79 86 3090 3097 O
recurrent 87 96 3098 3107 O
ER+/HER2- 97 106 3108 3117 O
disease 107 114 3118 3125 O
not 115 118 3126 3129 O
amenable 119 127 3130 3138 O
to 128 130 3139 3141 O
therapy 131 138 3142 3149 B-treatment
for 139 142 3150 3153 O
curative 143 151 3154 3162 B-treatment
intent 152 158 3163 3169 I-treatment

acute 0 5 3170 3175 B-chronic_disease
myocardial 6 16 3176 3186 I-chronic_disease
infarction 17 27 3187 3197 I-chronic_disease

congestive 0 10 3198 3208 B-chronic_disease
heart 11 16 3209 3214 I-chronic_disease
failure 17 24 3215 3222 I-chronic_disease

creatinine 0 10 3223 3233 B-clinical_variable
≤ 11 12 3234 3235 O
1.5 13 16 3236 3239 B-lower_bound
x 17 18 3240 3241 I-lower_bound
upper 19 24 3242 3247 I-lower_bound
limits 25 31 3248 3254 I-lower_bound
of 32 34 3255 3257 I-lower_bound
normal 35 41 3258 3264 I-lower_bound
( 42 43 3265 3266 I-lower_bound
ULN 43 46 3266 3269 I-lower_bound
) 46 47 3269 3270 I-lower_bound

deep 0 4 3271 3275 B-chronic_disease
venous 5 11 3276 3282 I-chronic_disease
thrombosis 12 22 3283 3293 I-chronic_disease

hemoglobin 0 10 3294 3304 B-clinical_variable
> 11 12 3305 3306 O
9 13 14 3307 3308 B-lower_bound
g 15 16 3309 3310 I-lower_bound
/ 16 17 3310 3311 I-lower_bound
dL 17 19 3311 3313 I-lower_bound

platelet 0 8 3314 3322 B-clinical_variable
count 9 14 3323 3328 I-clinical_variable
≥ 15 16 3329 3330 O
75,000 17 23 3331 3337 B-lower_bound
/ 23 24 3337 3338 I-lower_bound
uL 24 26 3338 3340 I-lower_bound
Serum 27 32 3341 3346 B-treatment
biochemistry 33 45 3347 3359 I-treatment
/ 45 46 3359 3360 O
metabolic 46 55 3360 3369 B-treatment
panel 56 61 3370 3375 I-treatment

previous 0 8 3376 3384 O
malignancy 9 19 3385 3395 B-cancer
not 20 23 3396 3399 O
treated 24 31 3400 3407 O
with 32 36 3408 3412 O
curative 37 45 3413 3421 B-treatment
intent 46 52 3422 3428 I-treatment
, 52 53 3428 3429 O
or 54 56 3430 3432 O
with 57 61 3433 3437 O
an 62 64 3438 3440 O
estimated 65 74 3441 3450 B-clinical_variable
recurrence 75 85 3451 3461 I-clinical_variable
risk 86 90 3462 3466 I-clinical_variable
≥30 91 94 3467 3470 O
% 94 95 3470 3471 I-lower_bound

pulmonary 0 9 3472 3481 B-chronic_disease
embolism 10 18 3482 3490 I-chronic_disease

surgical 0 8 3491 3499 B-treatment
biopsy 9 15 3500 3506 I-treatment
of 16 18 3507 3509 O
≥1 19 21 3510 3512 O
site(s 22 28 3513 3519 O
) 28 29 3519 3520 O
of 30 32 3521 3523 O
metastatic 33 43 3524 3534 B-cancer
or 44 46 3535 3537 O
locally 47 54 3538 3545 B-cancer
advanced 55 63 3546 3554 I-cancer
disease 64 71 3555 3562 I-cancer
performed 72 81 3563 3572 O
as 82 84 3573 3575 O
standard 85 93 3576 3584 O
of 94 96 3585 3587 O
care 97 101 3588 3592 O
within 102 108 3593 3599 O
the 109 112 3600 3603 O
past 113 117 3604 3608 B-upper_bound
4 118 119 3609 3610 I-upper_bound
months 120 126 3611 3617 I-upper_bound
for 127 130 3618 3621 O
assessment 131 141 3622 3632 O
of 142 144 3633 3635 O
eligibility 145 156 3636 3647 O
for 157 160 3648 3651 O
study 161 166 3652 3657 O
participation 167 180 3658 3671 O
( 181 182 3672 3673 O
except 182 188 3673 3679 O
as 189 191 3680 3682 O
noted 192 197 3683 3688 O
below 198 203 3689 3694 O
in 204 206 3695 3697 O
c 207 208 3698 3699 O
/ 208 209 3699 3700 O
d 209 210 3700 3701 O
/ 210 211 3701 3702 O
e 211 212 3702 3703 O
) 212 213 3703 3704 O

total 0 5 3705 3710 B-clinical_variable
bilirubin 6 15 3711 3720 I-clinical_variable
≤ 16 17 3721 3722 O
1.5 18 21 3723 3726 B-upper_bound
x 22 23 3727 3728 I-upper_bound
upper 24 29 3729 3734 I-upper_bound
limits 30 36 3735 3741 I-upper_bound
of 37 39 3742 3744 I-upper_bound
normal 40 46 3745 3751 I-upper_bound
( 47 48 3752 3753 I-upper_bound
ULN 48 51 3753 3756 I-upper_bound
) 51 52 3756 3757 I-upper_bound

white 0 5 3758 3763 B-clinical_variable
blood 6 11 3764 3769 I-clinical_variable
cell 12 16 3770 3774 I-clinical_variable
( 17 18 3775 3776 I-clinical_variable
WBC 18 21 3776 3779 I-clinical_variable
) 21 22 3779 3780 I-clinical_variable
count 23 28 3781 3786 I-clinical_variable
( 29 30 3787 3788 O
≥ 30 31 3788 3789 O
2,000 32 37 3790 3795 B-lower_bound
/ 37 38 3795 3796 I-lower_bound
uL 38 40 3796 3798 I-lower_bound
) 40 41 3798 3799 O

